Company Overview and News

[Press] Australia's Bass Hungry for More Onshore Indonesian Oil Acquisitions After Record March Production from Sumatran Field

2018-04-09 oilvoice
Record March output as Indonesian oil field production lifts ~21% on February levels as a result of optimisation work
Upvote Downvote

[Press] 20% Lift in Daily Indonesian Oil Output for Melbourne's Bass Oil

2018-04-04 oilvoice
Bass realises significant 20% uplift in daily field output at onshore oil production assets in South Sumatra
Upvote Downvote

[Press] Bass Oil: Indonesian Oil Field Productions – February Operations Update

2018-03-09 oilvoice
February oil sales totaled 14,616 barrels of oil (JV Share) or 8,038 barrels (net to Bass)
Upvote Downvote

Bass Oil achieves more than 20% month on month lift in oil production

Bass Oil Ltd (ASX:BAS) has achieved a substantial lift in oil production in February from its joint venture interest in the Tangai-Sukananti field.
Upvote Downvote

[Press] Major Boost for Australia's Bass Oil in Upgraded Potential for Producing Onshore Indonesian Oil Field

2018-03-05 oilvoice
Australia's Bass Oil Limited (ASX: BAS) is pleased to announce a major upgrade to the prospectivity of the Company's producing Tangai-Sukananti KSO, located in onshore Sumatra, Indonesia.
Upvote Downvote

Bass Oil receives record price of US$64.20 per barrel with production likely to increase

Bass Oil Ltd (ASX:BAS) and its joint venture partner sold a total of 17,260 barrels of oil or 9,493 barrels of oil net to Bass in January.
Upvote Downvote

Bass Strait Oil Company Ltd to reveal raising

The halt will remain in place until the opening of trade on Monday 21st November 2016, or earlier if an announcement is made to the market.
Upvote Downvote

Bass Strait Oil Company tops ASX % Gainers intra-day

Bass Strait Oil Company Ltd (ASX:BAS) is a specialist oil explorer focused exclusively on south-east Australia.
Upvote Downvote

Bass Strait Oil Company and Oil Basins Limited to relinquish Vic/P41

2016-10-03 oilvoice
Bass Strait Oil Company Limited advises that BAS and Oil Basins Limited (OBL) are planning to apply to the National Offshore Petroleum Titles Authority (NOPTA) for the surrender of their joint interest in Vic/P41. BAS and OBL have agreed that the forward work program is uneconomical and it is in all parties' interest to surrender the title. Once the final report is lodged with NOPTA and the filing fee paid, BAS will have no further interest in or costs in relation to Vic/P41.
Upvote Downvote

Letter to Shareholders

Upvote Downvote

Appendix 3B

Upvote Downvote

Cleansing Statement

Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

12h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...